JPS5812278B2 - Cinquinapiride (2,3-D) Pyrimidinedione - Google Patents
Cinquinapiride (2,3-D) PyrimidinedioneInfo
- Publication number
- JPS5812278B2 JPS5812278B2 JP74715A JP71574A JPS5812278B2 JP S5812278 B2 JPS5812278 B2 JP S5812278B2 JP 74715 A JP74715 A JP 74715A JP 71574 A JP71574 A JP 71574A JP S5812278 B2 JPS5812278 B2 JP S5812278B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- halogen atom
- lower alkyl
- substituted
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 125000005843 halogen group Chemical group 0.000 claims description 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000013078 crystal Substances 0.000 description 8
- 238000000921 elemental analysis Methods 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- -1 inglovil Chemical group 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- ZPFAVCIQZKRBGF-UHFFFAOYSA-N 1,3,2-dioxathiolane 2,2-dioxide Chemical compound O=S1(=O)OCCO1 ZPFAVCIQZKRBGF-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YKPZBJDSFGRTHP-UHFFFAOYSA-N 1,4-dihydropyrido[2,3-d]pyrimidine Chemical compound C1=CC=C2CN=CNC2=N1 YKPZBJDSFGRTHP-UHFFFAOYSA-N 0.000 description 1
- XKEBMWRWBWRQAO-UHFFFAOYSA-N 1h-pyrido[2,3-d]pyrimidin-4-one Chemical class C1=CC=C2C(=O)N=CNC2=N1 XKEBMWRWBWRQAO-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical group [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical group [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- SOCTUWSJJQCPFX-UHFFFAOYSA-N dichromate(2-) Chemical compound [O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O SOCTUWSJJQCPFX-UHFFFAOYSA-N 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000004820 halides Chemical group 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-O hydron;pyrimidine Chemical compound C1=CN=C[NH+]=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-O 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- BRMYZIKAHFEUFJ-UHFFFAOYSA-L mercury diacetate Chemical compound CC(=O)O[Hg]OC(C)=O BRMYZIKAHFEUFJ-UHFFFAOYSA-L 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000008512 pyrimidinediones Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は一般式(I)
(式中、
R1は
(1) フエニル基、
(2)ハロゲン原子、低級アルキル基、低級アルコキシ
基、ニトロ基、トリフルオロメチル基で置換されたフエ
ニル基、
(3)シクロアルキル基、
(4)ベンジル基、又は
(5)ハロゲン原子で置換されたベンジル基を、R2は
(1)低級アルキル基、
(2)ハロゲン原子、低級シクロアルキル基、アルコキ
シ基、アセチル基、水酸基、フエニル基で置換された低
級アルキル基、
(3)アルケニル基、又は
(4)アルキニル基、
を意味する)で表わされる新規なピリド〔2・3−d)
ピリミジンジオン誘導体の製造法に関するものである。Detailed Description of the Invention The present invention is based on the general formula (I) (wherein R1 is substituted with (1) a phenyl group, (2) a halogen atom, a lower alkyl group, a lower alkoxy group, a nitro group, or a trifluoromethyl group) phenyl group, (3) cycloalkyl group, (4) benzyl group, or (5) benzyl group substituted with a halogen atom, R2 is (1) lower alkyl group, (2) halogen atom, lower cycloalkyl A new pyrido [2.3-d) represented by a group, an alkoxy group, an acetyl group, a hydroxyl group, a lower alkyl group substituted with a phenyl group, (3) an alkenyl group, or (4) an alkynyl group)
The present invention relates to a method for producing pyrimidinedione derivatives.
更に詳しくは一般式(n)
(式中、R1及びR2は前記と同じ意味を有し、Xは
(1)ハロゲン原子、
(2)無機酸、又は
(3)有機酸のエステル基を、
Yは
(1)カルボニル基、
(2)チオカルボニル基、及び
(3)メチレン基、
を意味する)で表わされる化合物を酸化して、前記一般
式(I)で表わされる目的化合物を製造する方法に関す
るものである。More specifically, general formula (n) (wherein R1 and R2 have the same meanings as above, X represents (1) a halogen atom, (2) an inorganic acid, or (3) an ester group of an organic acid, Y (1) carbonyl group, (2) thiocarbonyl group, and (3) methylene group. It is something.
前記一般式(I)及び(n)におけるR1、R2及びX
に就いて更に詳細に説明すると、R1はフエニル基、又
は塩素、臭素、弗素、沃素等のハロゲン原子、メチル、
エチル等の低級アルキル基、メトキシ、エトキシ等の低
級ナルコキシ基、二トロ基及びトリフルオロメチル基等
が任意に1〜2個置換したフエニル基を、シクロアルキ
ル基はシクロヘキシル基又は低級アルキル置換シクロヘ
キシル基を、並びにベンジル基又はハロゲン原子で置換
されたベンジル基を表わす。R1, R2 and X in the general formulas (I) and (n)
To explain in more detail, R1 is a phenyl group, or a halogen atom such as chlorine, bromine, fluorine, or iodine, methyl,
A phenyl group optionally substituted with 1 or 2 lower alkyl groups such as ethyl, lower narkoxy groups such as methoxy and ethoxy, nitro groups and trifluoromethyl groups, and cycloalkyl groups are cyclohexyl groups or lower alkyl-substituted cyclohexyl groups. , and a benzyl group or a benzyl group substituted with a halogen atom.
R2の低級アルキル基はメチル、エチル、n−プロビル
、イングロビル、n−ブチル、イソブチル、ペンチル等
の低級アルキル基を、置換低級アルキル基はハロゲン原
子、低級シクロアルキル基、アルコキシ基、アセチル基
、水酸基及びフエニル基で置換された低級アルキル基を
、アルケニル基はアリル、3−メチルアリル、3 ・3
−ジメチルアリル等を、アルキニル基はプロパルギル等
を表わす。The lower alkyl group of R2 is a lower alkyl group such as methyl, ethyl, n-propyl, inglovil, n-butyl, isobutyl, pentyl, etc., and the substituted lower alkyl group is a halogen atom, lower cycloalkyl group, alkoxy group, acetyl group, or hydroxyl group. and a lower alkyl group substituted with a phenyl group, the alkenyl group is allyl, 3-methylallyl, 3 ・3
-dimethylallyl, etc., and an alkynyl group represents propargyl, etc.
Xは具体的にはハライド、トリフルオロアセテート、サ
ルフエート(例えば、CH3SOいC2H5SO4、F
SO3)、スルホネート(例えば、C2H,S03、C
a H5SOa)又はナイトレート等を意味する。Specifically, X is a halide, trifluoroacetate, sulfate (for example, CH3SO, C2H5SO4, F
SO3), sulfonates (e.g. C2H, S03, C
a H5SOa) or nitrate, etc.
本発明の出発原料である一般式(n)の4級塩は次に示
す方法で得られた1・4−ジヒドロピリド〔2・3−d
〕ピリミジン誘導体(III)、4−オキソー1・4−
ジヒドロピリド〔2・3−d〕ピリミジン誘導体(■)
、4−チオー1・4−ジヒドロビリド〔2・3−d〕ピ
リミジン誘導体(V)等にアルキルハライド、無機酸エ
ステル、又は有機酸エステルを反応させることによって
得られる。The quaternary salt of general formula (n), which is the starting material of the present invention, is 1,4-dihydropyrid [2,3-d
]Pyrimidine derivative (III), 4-oxo 1,4-
Dihydropyrido[2,3-d]pyrimidine derivative (■)
, 4-thio 1,4-dihydroviride [2,3-d]pyrimidine derivative (V) or the like with an alkyl halide, an inorganic acid ester, or an organic acid ester.
本発明を実施するには、前記の方法で得られた一般式(
II)で表わされる化合物に酸化剤を作用させることに
よって行なわれる。To carry out the present invention, the general formula (
This is carried out by reacting the compound represented by II) with an oxidizing agent.
使用する酸化剤としては過マンガン酸塩、二酸化マンガ
ン、重クロム酸塩、無水クロム酸、フエリシアン化カリ
ウム、二酸化セレン、酢酸第二水銀、過酸化水素又はオ
ゾン等が挙げられる。Examples of the oxidizing agent used include permanganate, manganese dioxide, dichromate, chromic anhydride, potassium ferricyanide, selenium dioxide, mercuric acetate, hydrogen peroxide, and ozone.
使用する溶媒は水、氷酢酸、硫酸、硝酸、アセトン、ジ
オキサン及びアルコール等の不活性溶媒中から適宜選択
される。The solvent used is appropriately selected from inert solvents such as water, glacial acetic acid, sulfuric acid, nitric acid, acetone, dioxane, and alcohol.
反応温度は特に限定されず室温又は加熱することによっ
て行なわれ、加熱すると反応時間は短縮される。The reaction temperature is not particularly limited, and the reaction can be carried out at room temperature or by heating, and heating shortens the reaction time.
本発明によって得られた化合物は文献未載の新規化合物
であり鎮痛作用、抗炎症作用及び中枢神経抑制作用等の
薬埋作用を有し、医薬品として産業上有用な化合物であ
る。The compound obtained by the present invention is a new compound that has not been described in any literature, and has medicinal effects such as analgesic action, anti-inflammatory action, and central nervous system depressing action, and is an industrially useful compound as a pharmaceutical.
次に実施例を挙げて本発明をさらに説明する。Next, the present invention will be further explained with reference to Examples.
実施例 1
1−(m−トリフルオロメチルフエニル)−3−メチル
−1・4−ジヒドロピリド〔2・3−d〕ピリミジニウ
ムアイオダイド2.9ク、氷酢酸30ml、無水クロム
酸3.01の混合物を3時間還流させた。Example 1 1-(m-trifluoromethylphenyl)-3-methyl-1,4-dihydropyrido[2,3-d]pyrimidinium iodide 2.9 ml, glacial acetic acid 30 ml, chromic anhydride 3. The mixture of 01 was refluxed for 3 hours.
反応終了後、減圧下に溶媒を留去し残渣に氷水を加え放
置して析出する結晶をメタノールより再結晶して、無色
プリズム晶の1−(m−トリフルオロメチルフエニル)
−3−メチルピリド〔2・3−d〕ピリミジン−2・4
( IH・3H)一ジオン2.3gを得た。After the reaction is complete, the solvent is distilled off under reduced pressure, ice water is added to the residue, and the crystals that precipitate are recrystallized from methanol to obtain colorless prismatic crystals of 1-(m-trifluoromethylphenyl).
-3-methylpyrido[2.3-d]pyrimidine-2.4
2.3 g of (IH·3H) monodione was obtained.
この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.
融点 224〜225℃
元素分析値 C15H1oF3N30
理論値 C:56.08 H:3.14N:13.0
8
実測値 C:56.12 H:3.05N:13.0
1
実施例 2
1−(m−トリフルオロメチルフエニル)−3−エチル
−1・4−ジヒドロピリド〔2・3−d〕ピリミジニウ
ムエトサルフエート3gと重クロム酸カリウム51の混
合物に濃硫酸一水(1:1)100mlを加え還流下3
時間反応させた。Melting point 224-225℃ Elemental analysis value C15H1oF3N30 Theoretical value C: 56.08 H: 3.14 N: 13.0
8 Actual value C: 56.12 H: 3.05 N: 13.0
1 Example 2 A mixture of 3 g of 1-(m-trifluoromethylphenyl)-3-ethyl-1,4-dihydropyrido[2,3-d]pyrimidinium ethosulfate and 51 potassium dichromate was added with concentrated sulfuric acid. Add 100ml of water (1:1) and reflux for 3 minutes.
Allowed time to react.
反応終了後、反応液を冷却し10%の炭酸ナトリウム溶
液にて中和し析出した結晶をメタノールより再結晶して
、無色プリズム晶の1−(m−トリフルオロメチルフエ
ニル)−3−エチルヒリド〔2・3−d)ピリミジン−
2・4(IH・3H)一ジオン1.8グを得た。After the reaction was completed, the reaction solution was cooled and neutralized with 10% sodium carbonate solution, and the precipitated crystals were recrystallized from methanol to obtain colorless prismatic crystals of 1-(m-trifluoromethylphenyl)-3-ethylhylide. [2.3-d) Pyrimidine-
1.8 g of 2.4 (IH.3H) dione was obtained.
この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.
融点 160〜162℃
元素分析値 C16 H12 F3 N3 o2理論値
C:57.31 H:3.61N:12.53
実測値 C:57.21 H:3.58N:12.4
9
実施例 3
1−(m−フルオロフエニル)−3−)チル−4−オキ
ソー1・4−−ジヒドロピリド〔2・3−d〕ピリミジ
ニウムメトサルフエート2.51と重クロム酸カリウム
5グの混合物に濃硫酸一水(1:1)100mlを加え
還流下3時間反応させた。Melting point 160-162℃ Elemental analysis value C16 H12 F3 N3 o2 Theoretical value C: 57.31 H: 3.61 N: 12.53 Actual value C: 57.21 H: 3.58 N: 12.4
9 Example 3 1-(m-fluorophenyl)-3-)thyl-4-oxo 1,4-dihydropyrido[2,3-d]pyrimidinium methosulfate 2.51 and potassium dichromate 5 100 ml of concentrated sulfuric acid/water (1:1) was added to the mixture and reacted under reflux for 3 hours.
反応終了後、反応液を冷却し10%の炭酸ナトリウム溶
液にて中和し析出した結晶をメタノールより再結晶して
、無色プリズム晶の1−(m−フルオロフエニル)−3
−メチルヒリド〔2・3−d)ピリミジンー2・4(I
H・3H)一ジオン1.5グを得た。After the reaction was completed, the reaction solution was cooled and neutralized with 10% sodium carbonate solution, and the precipitated crystals were recrystallized from methanol to obtain colorless prismatic crystals of 1-(m-fluorophenyl)-3.
-Methylhylide[2,3-d)pyrimidine-2,4(I
1.5 g of H.3H) monodione was obtained.
この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.
融点 197〜198°C
元素分析値 C14 HIO FN3 o2理論値 C
:61.99 H:3.72N:15.49
実測値 C:61.83 H:3.61N:15.3
8
実施例 4
1−(m−クロロフエニル)−3−エチル−1−4−ジ
ヒドロピリド〔2・3−d〕ピリミジニウムエトサルフ
エート3gと重クロム酸カリウム5グの混合物に氷酢酸
100mlを加え還流下3時間反応させた。Melting point 197-198°C Elemental analysis value C14 HIO FN3 o2 theoretical value C
:61.99 H:3.72N:15.49 Actual value C:61.83 H:3.61N:15.3
8 Example 4 100 ml of glacial acetic acid was added to a mixture of 3 g of 1-(m-chlorophenyl)-3-ethyl-1-4-dihydropyrido[2.3-d]pyrimidinium ethosulfate and 5 g of potassium dichromate. The reaction was carried out under reflux for 3 hours.
反応終了後、溶媒を減圧下で留去し残渣に水を加えて析
出した結晶をメタノールより再結晶して、無色プリズム
晶の1−(m−クロロフエニル)−3−エチルピリド〔
2・3−d〕ピリミジンー2・4(IH・3H)一ジオ
ン1.5?を得た。After the reaction, the solvent was distilled off under reduced pressure, water was added to the residue, and the precipitated crystals were recrystallized from methanol to obtain colorless prismatic crystals of 1-(m-chlorophenyl)-3-ethylpyrid [
2.3-d] pyrimidine-2.4(IH・3H)-dione 1.5? I got it.
この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.
融点 176〜177℃
元素分析値 C15H12CIN302
理論値 C:59.71 H:4.01N:13.9
3
実測値 C:59.69 H:4.03N:l3.8
7
実施例 5〜130
実施例1〜4の方法に準じて次表に示す化合物を好収率
で得た。Melting point 176-177℃ Elemental analysis value C15H12CIN302 Theoretical value C: 59.71 H: 4.01 N: 13.9
3 Actual value C: 59.69 H: 4.03 N: l3.8
7 Examples 5 to 130 According to the method of Examples 1 to 4, the compounds shown in the following table were obtained in good yield.
Claims (1)
基、二トロ基、トリフルオロメチル基で置換されたフエ
ニル基、 (3)シクロアルキル基 (4)ベンジル基、又は (5)ハロゲン原子で置換されたベンジル基を、R2は (1)低級アルキル基、 (2) ハロゲン原子、低級シクロアルキル基、アル
コキシ基、アセチル基、水酸基、フェニル基で置換され
た低級アルキル基、 (3)アルケニル基、又は (4)アルキニル基を、 Xは (1) ハロゲン原子、 (2)無機酸、又は (3)有機酸のエステル基を、 Yは (1) カルボニル基、 (2)チオカルボニル基、又は (3)メチレン基、 を意味する)で表わされる化合物を酸化することを特徴
とする一般式 (式中、R1及びR2は前記と同じ意味を有する)で表
わされる新規なピリド〔2・3−d〕ピリミジンジオン
誘導体の製造法。[Scope of Claims] 1 General formula (wherein R1 is (1) a phenyl group, (2) a phenyl group substituted with a halogen atom, a lower alkyl group, a lower alkoxy group, a nitro group, a trifluoromethyl group, (3) cycloalkyl group (4) benzyl group, or (5) benzyl group substituted with a halogen atom, R2 is (1) lower alkyl group, (2) halogen atom, lower cycloalkyl group, alkoxy group, acetyl , hydroxyl group, lower alkyl group substituted with phenyl group, (3) alkenyl group, or (4) alkynyl group, and X is (1) halogen atom, (2) inorganic acid, or (3) ester of organic acid. group, Y means (1) carbonyl group, (2) thiocarbonyl group, or (3) methylene group) (wherein R1 and R2 has the same meaning as above).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP74715A JPS5812278B2 (en) | 1973-12-31 | 1973-12-31 | Cinquinapiride (2,3-D) Pyrimidinedione |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP74715A JPS5812278B2 (en) | 1973-12-31 | 1973-12-31 | Cinquinapiride (2,3-D) Pyrimidinedione |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS50100081A JPS50100081A (en) | 1975-08-08 |
| JPS5812278B2 true JPS5812278B2 (en) | 1983-03-07 |
Family
ID=11481446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP74715A Expired JPS5812278B2 (en) | 1973-12-31 | 1973-12-31 | Cinquinapiride (2,3-D) Pyrimidinedione |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5812278B2 (en) |
-
1973
- 1973-12-31 JP JP74715A patent/JPS5812278B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS50100081A (en) | 1975-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3713724B2 (en) | Method for producing imidazopyridine derivative | |
| ES2962961T3 (en) | Preparation procedure of n-(5-((4-(4-(dimethylamino)methyl)-3-phenyl-1h-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl )acrylamide by reacting the corresponding amine with a 3-halo-propionyl chloride | |
| ES2923278T3 (en) | Useful intermediates for the synthesis of aminopyrimidine derivatives, process for preparing the same and process for preparing aminopyrimidine derivatives using the same | |
| US3923710A (en) | Production of quinazolinone compounds | |
| US2592930A (en) | Method for preparing vitamin b | |
| JPS5812278B2 (en) | Cinquinapiride (2,3-D) Pyrimidinedione | |
| JPH061776A (en) | Production of substituted pyrazinecarbonitrile | |
| JPS5813550B2 (en) | Sinquinapiride (4,3-D) Pyrimidinedione | |
| JPS5920676B2 (en) | Method for producing a novel pyrimido[4,5-d]pyrimidine derivative | |
| CN119504606A (en) | Method for preparing fluoropyrimidine ester derivatives | |
| JPS5833232B2 (en) | Sinquinapyridopyrimidinedione | |
| JPS5813546B2 (en) | Sinquinapyridopyrimidinedione | |
| JPS5829792B2 (en) | Sinquinapiride (4,3-D) Pyrimidinedione | |
| JPS5813547B2 (en) | Cinquinapiride (2,3-D) Pyrimidinedione | |
| JPS5995286A (en) | Imidazo(4,5-c)pyridine-6-carboxylic acid derivative | |
| PL126876B1 (en) | Method of obtaining new alpha-acyloxyacetamides | |
| JP3016104B2 (en) | 1H-pyrrolo- [1,2-b] [1,2,4] triazole derivative | |
| JPS5850229B2 (en) | Manufacturers of novel pyrido[2,3-d]pyrimidine derivatives | |
| JPS5920677B2 (en) | Method for producing a novel pyrimido[4,5-d]pyrimidinedione derivative | |
| JPS5827795B2 (en) | Synquina 4-oxo-1,4-dihydropyrido (2,3-D) Pyrimidine | |
| JPS5854158B2 (en) | Synquinapyridothiadiagin | |
| JPS5920675B2 (en) | Method for producing a novel pyrimido[4,5-d]pyrimidine derivative | |
| JPS5826757B2 (en) | Sinquinapyrimide (4 5-D) pyrimidine | |
| JPS5829310B2 (en) | Synquina 4-oxo-1234-tetrahydropyrido (2,3-D) pyrimidine | |
| JPS5813553B2 (en) | Sinquinapiride (4,3-D) Pyrimidinedione |